# 1. Financial Performance ## A. Key Figures * **Returns:** **9.4%** ROCE · **10.6%** RONOA ## B. Revenue & Realization * **Price-Volume Divergence:** Top-line contraction was driven by a significant decline in price realization, which more than offset modest volume growth. * **Segmental Headwinds:** The Chemicals business saw a top-line drop of **₹120 Cr**, while Performance Materials and Monomers also faced sales pressure. * **Agricultural Outlook:** Lower net product offtake impacted the Agro segment, though management maintains solid leading indicators for quality and safety. ## C. Profitability & Margins * **Margin Compression:** Profitability was hampered by higher raw material costs and an unfavorable product mix, particularly in the Agricultural Solutions segment. * **Opex Inflation:** Operating expenses rose as a percentage of sales due to **SAP system upgrades**, foreign exchange hedging, and higher severance/employee costs. * **Cost Restructuring:** Management is recalibrating the cost structure to prevent core chemicals from absorbing overheads previously tied to the Agro division. * **Royalty Dynamics:** Royalty expenses (ranging from **1.5% to 13%**) are sensitive to product mix shifts rather than aggregate sales volume. ## D. Working Capital & Cash Flow * **Working Capital Expansion:** A sharp increase in net working capital was primarily triggered by a **₹750 Cr** reduction in accounts payable and elevated inventory. * **Cash Flow Pressure:** Operating cash flow declined by **₹900 Cr**, reflecting the payables reduction and a slight increase in receivable days to **65 days**. * **Inventory Strategy:** Current elevated inventory levels are concentrated in the Agro segment; liquidation is expected during the upcoming season. * **Balance Sheet Strength:** Despite global parent deleveraging, the Indian entity remains **debt-free** with a focus on improving free cash flow and Return on Sales (ROSI). --- # 2. Segment & Product Performance ## A. Agricultural Solutions Portfolio * **New Product Success:** Rapid adoption of rice-market launches, with **Valexio** insecticide reaching top-10 status within its first year. * **Portfolio Diversification:** Division stability underpinned by **26 products** generating over **₹10 Cr** each, though overall growth momentum for recent novel introductions has subsided. * **Macro Headwinds:** Soft commodity prices in **chile, soybeans, and cotton** are dampening farmer investment, offset partially by a strategic pivot toward specialty crops and rice. * **Innovation Focus:** Long-term strategy prioritizes high-margin innovative mixtures and hybrids to mitigate geopolitical supply chain risks. ## B. Nutrition & Care * **Outsized Profitability:** Segment earnings surged driven by a rare "twin-engine" growth of both volume and pricing power. * **Sub-segment Divergence:** Strong performance was led by the **Nutrition and Health** unit (profits nearly doubled to **₹27 Cr**), while **Care Chemicals** manufacturing lagged significantly at **₹2 Cr**. ## C. Industrial & Surface Solutions * **Structural Realignment:** Process catalyst operations moved to Industrial Solutions; the unit maintains a healthy pipeline tied to upcoming **petrochemical projects**. * **Margin Expansion Targets:** Management is targeting EBIT improvement above current levels through localized production and portfolio optimization. * **Competitive Pressures:** The Dispersions business (construction/paints) is seeing volume gains but faces intense pricing competition; Surface Tech performance was hindered by **one-time legal entity setup costs**. ## D. Materials & Monomers * **Volume Contraction:** Significant top-line erosion primarily attributed to a sharp contraction in Monomers volume and pricing softness in Performance Materials. * **Operational Resilience:** Maintaining momentum in India via **increased Original Manufacturer Polymer (OMP) share** and aggressive cost-control measures to ensure full asset utilization. --- # 3. Manufacturing & Capacity ## A. Capacity Expansion & Localization * **Strategic Import Substitution:** Construction of a new Cellesto facility and upgrades at Dahej aim to localize production currently sourced from Germany, expected to bolster the bottom line. * **Infrastructure Modernization:** Expansion at the Thane site includes reactivating vessels for system house production and upgrading quality control labs to support increased output. * **Future-Proofing Assets:** New investments are scheduled for commissioning in the **second half of 2026**, focusing on high-demand polyurethane and engineering plastics to sustain market leadership. ## B. Operational Efficiency & Safety * **Utilization Advantage:** Domestic operations maintain high utilization rates, significantly outperforming the underutilized asset base currently seen in Western Europe. * **Automation & Profitability:** Ongoing investments in production line modernization and increased automation are targeted to drive long-term operational efficiency. * **Safety Culture:** Strong year-to-date safety record supported by Global Safety Days training involving over **900 employees** to reinforce process integrity. ## C. Global Context * **Cycle Management:** The massive capital expenditure in China is entering the market during a low chemical cycle, necessitating high global asset utilization to absorb the new capacity. --- # 4. Strategic Initiatives & M&A ## A. Agricultural Business Demerger * **Value Unlocking via Demerger:** Progressing with the carve-out of the Agricultural Solutions business into a new listed entity, mirroring global "differentiated steering" strategies. * **Shareholder Neutrality:** Implementation of a **1:1 share entitlement ratio** for the new entity, with final completion targeted for **FY 2026-27** pending regulatory approvals. ## B. Coatings Global Divestiture * **Strategic Transition to Standalone:** Binding agreement with Carlyle to transition the coatings business globally; the Indian arm was incorporated as a wholly-owned subsidiary on **January 1, 2025**. * **Transaction Timeline:** Global closing expected by **Q2 CY2026**, with the specific local impact on the Indian subsidiary currently under evaluation. ## C. Portfolio Mix Optimization * **Margin Accretion Strategy:** Shifting focus toward high-value segments (UV filters, personal care) while intentionally reducing exposure to low-margin oleochemical and tolling volumes. * **Core Integration:** Post-demerger strategy emphasizes strengthening "core" segments deeply integrated within the chemical value chain through both organic and inorganic routes. ## D. Green Energy Transition * **Operational Efficiency:** Secured a **25-year hybrid solar and wind agreement** to significantly boost renewable consumption, expected to drive meaningful cost savings at key manufacturing sites. --- # 5. Market & Growth Opportunities ## A. Automotive & EV Transition * **EV Strategic Pivot:** Targeting the electric vehicle transition in Indian 2W and 4W markets by leveraging Performance Materials and cathode active materials. * **Portfolio Optimization:** Performance Chemicals unit benefiting from automotive expansion and a growing **Enhanced Oil Recovery (EOR)** portfolio, expected to enhance the overall business mix. * **Sector Tailwinds:** Anticipated growth in Fuel and Lubricant Solutions supported by domestic automotive expansion and potential **GST cuts**. * **Material Substitution:** High growth potential identified in the 2W and 3W segments as manufacturers shift production from traditional rubber to Celesto materials. ## B. FMCG & Premiumization Trends * **Consumption Recovery:** Lower inflation and favorable GST conditions are driving momentum in premium segments, specifically skin care, hair care, and flavors and fragrances. * **Agricultural Headwinds:** Excessive monsoon rains have negatively impacted crop yields and agricultural inputs, creating a temporary drag on rural-linked segments. * **Paint Industry Normalization:** Demand is stabilizing following a period of flat growth and high channel inventory caused by new entrants like **Opus**; stronger off-take noted in the last **2–3 months**. ## C. Agricultural Innovation Pipeline * **Yield Optimization:** Long-term global growth driven by the necessity for higher yields per hectare due to limited arable land and a rising population. * **R&D Focus:** Growth centered on technological innovations in seed treatment and crop protection to combat increasing weed and disease resistance. ## D. Domestic Consumption Drivers * **Macroeconomic Foundation:** Growth underpinned by domestic consumption—representing **two-thirds of GDP**—and a structural shift toward premiumization across key sectors. --- # 6. Risks & Chemical Industry Factors ## A. Chinese Overcapacity Pressure * **Upstream Pricing Headwinds:** Performance Materials and Monomers face sustained pricing compression driven by significant Chinese overcapacity; management expects no immediate relief. * **Additives Market Saturation:** The Plastic Additives segment (antioxidants/UV stabilizers) remains under pressure as Chinese producers aggressively push volume into global markets. ## B. Geopolitical & Tariff Risks * **Macroeconomic Vulnerability:** Despite resilient consumer confidence, the industry outlook is clouded by escalating geopolitical tensions and the threat of **US tariff actions**. ## C. Climate & Monsoon Impact * **Weather-Induced Sales Contraction:** Excessive and untimely rainfall led to the cancellation of spraying activities, resulting in a significant top-line hit to Agricultural Solutions. * **Inventory Overhang:** Regional flooding has triggered a buildup of **channel inventory**, potentially dampening new sales velocity in the near term. --- # 7. Guidance & Outlook ## A. Rabi Season & Macro Outlook * **Agricultural Optimism:** Favorable reservoir levels underpin a positive outlook for the Rabi season, expected to drive momentum across the product portfolio. * **Economic Expansion:** Upward revisions to national GDP and a robust PMI reading signal a strengthening domestic macroeconomic environment. ## B. Pricing & Capex Strategy * **Prolonged Pricing Pressure:** Upstream chemical pricing faces a difficult recovery path through **2026**, constrained by Chinese overcapacity and geopolitical tariff headwinds. * **Disciplined Capital Allocation:** Global Capex is projected to trail depreciation levels until **2028**; however, India remains a prioritized destination for strategic investment.